Datascope Gets FDA Approval to Sell Second Generation VasoSeal

Datascope Corp. has received FDA approval to market VasoSeal ES, its second generation arterial puncture sealing device. The company said it expects to begin selling the new device in the U.S. in the next fiscal quarter.

VasoSeal ES retains the proprietary, extravascular technology of the original VasoSeal VHD, but features a one-size-fits-all design that eliminates the need to measure skin-to-artery distance and the hospital's need to stock more than one size device. VasoSeal ES also becomes the first vascular sealing device to be approved for use on patients with peripheral vascular disease, a significant portion of the total patient population.